NMPA Approval

Erdafitinib Tablets

Approval Number

国药准字HJ20250007

Registration Date

January 8, 2025

Drug Information

Generic Name

厄达替尼片

Trade Name

博珂

Dosage Form

片剂

Strength

3mg

Drug Type

化学药品

Registration Date

January 8, 2025

Expiry Date

January 7, 2030

Company Address

800/850 Ridgeview Drive, Horsham, PA 19044, United States of America

Company Address

Via C. Janssen, Borgo San Michele, 04100 Latina, Italy

Empowering clinical research with data-driven insights and AI-powered tools.